LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Brain Imaging
- 1st Edition, Volume 165 - August 31, 2019
- Editor: David B. Teplow
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 1 8 3 6 1 - 8
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 8 3 6 2 - 5
Brain Imaging, Volume 164, the latest release in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research top… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteBrain Imaging, Volume 164, the latest release in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to neuroimaging in aging and neurodegenerative disease. Topics covered in this new release include FTD spectrum, Cerebrovascular disease, HIV, Huntington’s Disease, Development of brain PET imaging agents, and Disclosure of imaging biomarker results.
- Includes comprehensive coverage of molecular biology
- Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
- Contains contributions from renowned experts in the field
Scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. Also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work
FTD spectrum
Cerebrovascular disease
HIV
Huntington’s Disease
Development of brain PET imaging agents
Disclosure of imaging biomarker results
- No. of pages: 441
- Language: English
- Edition: 1
- Volume: 165
- Published: August 31, 2019
- Imprint: Academic Press
- Hardback ISBN: 9780128183618
- eBook ISBN: 9780128183625
DT
David B. Teplow
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Co-Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.
Affiliations and expertise
Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USARead Brain Imaging on ScienceDirect